Unlocking CRC Treatment: Targeting the Fibroblast and Macrophage Partnership
Image credit: https://openai.com/index/dall-e/ Colorectal cancer (CRC) is a very common type of cancer, and treatment options beyond surgery can be quite limited. While immunotherapy, which helps your own immune system fight cancer, has shown great success in some cancers like melanoma and lung cancer, it's currently only effective for a small number of metastatic CRC cases. This means it's really important to understand more about the environment within and around the tumour – known as the tumour microenvironment (TME) – to find new ways to improve treatments. This study looked closely at the cells making up the TME in CRC, analysing over 54,000 cells from both tumour tissue and nearby normal tissue. They used advanced techniques like single-cell RNA sequencing, which lets researchers see the genetic activity in individual cells, and spatial transcriptomics, which shows where different cells are located within the tissue. One of the main findings was ...